Analytical Data
-
Gene name
ZNF625
- Application
-
Alternative Names
ZNF625Zinc finger Protein 625
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96I27
-
Expression Region
1-306 aa
-
AA Sequence
MGERLLESKKDHQHGEILTQVPDDMLKKKTPRVKSCGEVSVGHASLNRHHRADTGHKPYEYQEYGQKPYKCTYCKKAFSDLPYFRTHEWAHTGGKPYDCEECGKSFISRSSIRRHRIMHSGDGPYKCNFCGKALMCLSLYLIHKRTHTGEKPYECKQCGKAFSHSGSLRIHERTHTGEKPYECSECGKAFHSSTCLHAHKITHTGEKPYECKQCGKAFVSFNSVRYHERTHTGEKPYECKQCGKAFRSASHLRTHGRTHTGEKPYECKQCGKAFGCASSVKIHERTHTGEKPCSSNTSKGQGEKIA
-
Molecular Weight
33.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNF625 (Zinc Finger Protein 625) is a member of the zinc finger protein family, known for its role in transcriptional regulation and involvement in various cellular processes. Recent studies have highlighted its potential significance in modulating gene expression related to cell proliferation, differentiation, and apoptosis. Abnormalities in ZNF625 expression have been implicated in several diseases, including cancer, making it a target of interest for therapeutic strategies. The protein's unique structure, characterized by multiple zinc finger motifs, allows it to interact with specific DNA sequences and other proteins, influencing signaling pathways and transcriptional networks. Given the rising incidence of cancer and the demand for innovative treatment approaches, the recombinant expression and functional characterization of ZNF625 is crucial. This research aims to elucidate the protein's functional mechanisms and explore its potential as a biomarker or therapeutic target. Advances in recombinant DNA technology have enabled the production of ZNF625 in suitable expression systems, facilitating in-depth studies of its structure-function relationships and biological roles. Understanding ZNF625’s mechanisms may lead to the development of novel interventions for diseases associated with its dysregulation.
